Issue 48: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.

As healthcare evolves with value-based, patient-centric approaches, both digital and human-led engagement have remained key tools to drive transformation. By focusing on building stronger HCP relationships, delivering holistic solutions and strengthening brand reputation, patient outcomes will be enhanced. Empower your field force and equip them with new digital tools and data analytics to drive personalised omnichannel strategies and engagement approaches, whilst not forgetting the human touch.?? ?

Join leading experts on Tuesday 18th February at 4pm CET to equip yourself with the actionable strategies needed to deliver more impactful HCP engagement during the webinar: ‘Elevate Omnichannel Engagement in a Value-based and Personalised Healthcare Era’.? ?

Register now to optimise your omnichannel engagement strategy for 2025 and beyond – webinar available to watch live or on demand! https://bit.ly/40ogLcq

Exclusive learnings from:?

- Tomas Ruzicka, Associate Director, Field Engagement & Country CX, Novartis?

- Kristina Kurs, Associate Director, Omnichannel Go-to-Market, Takeda?

- Gaurav Lalwani, Global Senior Director, Content & Omnichannel Marketing Operations, GSK?

- Donna Judd, Medical Channel Strategy Team Lead, Global Chief Medical Affairs Office, Pfizer?

Don’t miss out! Secure your place at the webinar now – watch live or access the recording later: https://bit.ly/40ogLcq

?? Dive into the evolving world of Independent Medical Education (IME) and learn how to tailor education to meet global and local demands of HCPs. Discover with Wiley why audience research is key to aligning IME initiatives with unmet medical needs. Read the full summary and access the recording here.

#IME #MedicalEducation #REpharma

Top 5 pharma news to watch:

1. Six million people could die from HIV and AIDS if US funding stops, UN agency warns (Reuters.com, Feb 7)
2. Bristol Myers gives first peek at closely watched launch of schizophrenia drug (Biopharma Dive, Feb 6)
3. What should pharma make of the FDA going dark on DEI? (Pharma Voice, Feb 4)
4. MSD starts pivotal trial of ROR1 drug in first-line lymphoma (pharmaphorum, Feb 7)
5. Novo's Mim8 inches closer to Hemlibra with new haemophilia data in kids (FirstWord Pharma, Feb 7)

Event spotlight

???Calling all Digital Health Startups!??? https://bit.ly/3Q3kSpo

For 23 years, Reuters Events Pharma in Barcelona has been a hub for industry collaboration. Now, we're excited to welcome digital innovators to the stage! ???

Join the Digital Health Start-Up Challenge for a chance to:

• Pitch your solution to key pharma decision-makers
• Gain valuable exposure for your company
• Network with 1,000+ senior pharma leaders
• Deliver a keynote presentation at Reuters Events: Pharma 2025

Apply today!??? https://bit.ly/3Q3kSpo

#digitalhealth #startups #innovation #pharma #REpharma

Thanks for reading! If you have any feedback or would like to see something included in our newsletter, get in touch with our team!

EU Team

Daisy Beale

Ziyanda Dludla

Suzy Wang

Emma Haslam

USA Team

Charlotte Bastiaanse

Noah Dixon

Jacob Byerley

Samuel Baddeley

See you next time!